SIM4FLOW
Lemesos
About SIM4FLOW
An Innovative Healthtech startup dedicated to revolutionizing cerebrovascular and cardiovascular diagnostics through cutting-edge technologies, specifically Simulation-Based Imaging (SBI) and Explainable Artificial Intelligence (xAI). Our project focuses on enhancing the prediction of intracranial aneurysm rupture risk and providing real-time 4D Flow MRI imaging for cardiovascular diseases. Innovative Approach SBI integrates advanced computational modeling with medical imaging, enabling clinicians to make more informed decisions based on accurate and actionable insights. By combining high-resolution imaging with xAI, we enhance the transparency and interpretability of AI-driven diagnostics, addressing the critical need for reliable tools in cerebrovascular and cardiovascular imaging. Key Objectives 1. Intracranial Aneurysm Rupture Risk Prediction: Using xAI, we analyze blood flow patterns and vessel wall stress to provide clinicians with actionable information that enhances preventive treatment strategies for patients at risk of aneurysm rupture. 2. Enhanced Imaging Capabilities: Our technology significantly improves spatial resolution by up to 6 times greater than conventional methods, while reducing scan times by up to 80%. This allows for faster patient work-up and more detailed image visualization of cardiovascular and cerebrovascular structures. 3. Versatile Applications: Sim4Flow’s innovative solutions are adaptable across various imaging modalities, including MRI and CT, making them suitable for a range of applications, including heart disease and abdominal aortic aneurysms. 4. Real-Time Diagnostics: By enabling real-time image reconstruction, SBI enhances clinical workflows and allows for immediate, well-informed decision-making, thereby improving patient outcomes. Collaborations and Partnerships The startup seeks partnerships with healthcare providers, medtech companies, and research institutions to advance our mission. We are particularly interested in collaborations for AI model training, image analysis, and clinical validation. In addition, we aim to engage in international and regional programs, such as Horizon Europe and Interreg, to foster further development and dissemination of our technology. Conclusion: Leveraging the power of SBI and xAI, Sim4Flow is poised to transform the landscape of cerebrovascular and cardiovascular diagnostics. Our innovative approach not only improves clinical outcomes, but also aims to reduce healthcare costs and improve patient’s the quality of life. Join us on this groundbreaking journey to advance precision diagnostics and redefine the future of cardiovascular healthcare.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $260.1K
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: sim4flow.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/sim4flow-100446 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.